Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2019

01-08-2019 | Insomnia | Case report

Mefloquine

Naevi eruption: case report

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

A 49-year-old woman developed naevi eruption during treatment with mefloquine for malaria chemoprophylaxis. This case was notified to the Tunisian national centre of pharmacovigilance. …
Literature
Metadata
Title
Mefloquine
Naevi eruption: case report
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65636-z

Other articles of this Issue 1/2019

Reactions Weekly 1/2019 Go to the issue

Case report

Multiple drugs

Case report

Ipilimumab/nivolumab

Case report

Doxorubicin/trastuzumab

Case report

Ipilimumab/nivolumab

Case report

Ibrutinib

Case report

Temozolomide/unspecified granulocyte colony stimulating factors